210 related articles for article (PubMed ID: 32559179)
1. GALNT6 promotes breast cancer metastasis by increasing mucin-type O-glycosylation of α2M.
Liu C; Li Z; Xu L; Shi Y; Zhang X; Shi S; Hou K; Fan Y; Li C; Wang X; Zhou L; Liu Y; Qu X; Che X
Aging (Albany NY); 2020 Jun; 12(12):11794-11811. PubMed ID: 32559179
[TBL] [Abstract][Full Text] [Related]
2. Critical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesis.
Park JH; Nishidate T; Kijima K; Ohashi T; Takegawa K; Fujikane T; Hirata K; Nakamura Y; Katagiri T
Cancer Res; 2010 Apr; 70(7):2759-69. PubMed ID: 20215525
[TBL] [Abstract][Full Text] [Related]
3. Critical Role of Estrogen Receptor Alpha O-Glycosylation by N-Acetylgalactosaminyltransferase 6 (GALNT6) in Its Nuclear Localization in Breast Cancer Cells.
Deng B; Tarhan YE; Ueda K; Ren L; Katagiri T; Park JH; Nakamura Y
Neoplasia; 2018 Oct; 20(10):1038-1044. PubMed ID: 30208353
[TBL] [Abstract][Full Text] [Related]
4. The GALNT6‑LGALS3BP axis promotes breast cancer cell growth.
Kimura R; Yoshimaru T; Matsushita Y; Matsuo T; Ono M; Park JH; Sasa M; Miyoshi Y; Nakamura Y; Katagiri T
Int J Oncol; 2020 Feb; 56(2):581-595. PubMed ID: 31894262
[TBL] [Abstract][Full Text] [Related]
5. GALNT6 expression enhances aggressive phenotypes of ovarian cancer cells by regulating EGFR activity.
Lin TC; Chen ST; Huang MC; Huang J; Hsu CL; Juan HF; Lin HH; Chen CH
Oncotarget; 2017 Jun; 8(26):42588-42601. PubMed ID: 28388560
[TBL] [Abstract][Full Text] [Related]
6. GALNT6 promotes invasion and metastasis of human lung adenocarcinoma cells through O-glycosylating chaperone protein GRP78.
Song J; Liu W; Wang J; Hao J; Wang Y; You X; Du X; Zhou Y; Ben J; Zhang X; Ye M; Wang Q
Cell Death Dis; 2020 May; 11(5):352. PubMed ID: 32393740
[TBL] [Abstract][Full Text] [Related]
7. RUNX3-Regulated GALNT6 Promotes the Migration and Invasion of Hepatocellular Carcinoma Cells by Mediating O-Glycosylation of MUC1.
Gao F; Zheng G
Dis Markers; 2022; 2022():2959846. PubMed ID: 35909886
[TBL] [Abstract][Full Text] [Related]
8. GALNT6 Stabilizes GRP78 Protein by O-glycosylation and Enhances its Activity to Suppress Apoptosis Under Stress Condition.
Lin J; Chung S; Ueda K; Matsuda K; Nakamura Y; Park JH
Neoplasia; 2017 Jan; 19(1):43-53. PubMed ID: 28110670
[TBL] [Abstract][Full Text] [Related]
9. Morphological Changes, Cadherin Switching, and Growth Suppression in Pancreatic Cancer by GALNT6 Knockdown.
Tarhan YE; Kato T; Jang M; Haga Y; Ueda K; Nakamura Y; Park JH
Neoplasia; 2016 May; 18(5):265-272. PubMed ID: 27237318
[TBL] [Abstract][Full Text] [Related]
10. Polypeptide N-acetylgalactosaminyltransferase 6 disrupts mammary acinar morphogenesis through O-glycosylation of fibronectin.
Park JH; Katagiri T; Chung S; Kijima K; Nakamura Y
Neoplasia; 2011 Apr; 13(4):320-6. PubMed ID: 21472136
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy and Male Breast Cancer: A Population-based Registry Analysis.
Madden NA; Macdonald OK; Call JA; Schomas DA; Lee CM; Patel S
Am J Clin Oncol; 2016 Oct; 39(5):458-62. PubMed ID: 24781343
[TBL] [Abstract][Full Text] [Related]
12. GALNT6 Promotes Tumorigenicity and Metastasis of Breast Cancer Cell via β-catenin/MUC1-C Signaling Pathway.
Mao Y; Zhang Y; Fan S; Chen L; Tang L; Chen X; Lyu J
Int J Biol Sci; 2019; 15(1):169-182. PubMed ID: 30662357
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of different GalNAc‑transferases is associated with disease progression and poor prognosis in women with high-grade serous ovarian cancer.
Sheta R; Bachvarova M; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Popa I; Bachvarov D
Int J Oncol; 2017 Dec; 51(6):1887-1897. PubMed ID: 29039611
[TBL] [Abstract][Full Text] [Related]
14. Correlation between activation of PI3K/AKT/mTOR pathway and prognosis of breast cancer in Chinese women.
Deng L; Chen J; Zhong XR; Luo T; Wang YP; Huang HF; Yin LJ; Qiu Y; Bu H; Lv Q; Zheng H
PLoS One; 2015; 10(3):e0120511. PubMed ID: 25816324
[TBL] [Abstract][Full Text] [Related]
15. Polypeptide
Guo Y; Shi J; Zhang J; Li H; Liu B; Guo H
Onco Targets Ther; 2017; 10():3337-3344. PubMed ID: 28744137
[TBL] [Abstract][Full Text] [Related]
16.
Zhu X; Zhang Y; Bai Y; Gu X; Chen G; Sun L; Wang Y; Qiao X; Ma Q; Zhu T; Bu J; Xue J; Liu C
Int J Med Sci; 2020; 17(17):2773-2789. PubMed ID: 33162805
[TBL] [Abstract][Full Text] [Related]
17. Hsa_circ_001569 is an unfavorable prognostic factor and promotes cell proliferation and metastasis by modulating PI3K-AKT pathway in breast cancer.
Xu JH; Wang Y; Xu D
Cancer Biomark; 2019; 25(2):193-201. PubMed ID: 31104012
[TBL] [Abstract][Full Text] [Related]
18. EIF3H Orchestrates Hippo Pathway-Mediated Oncogenesis via Catalytic Control of YAP Stability.
Zhou Z; Zhou H; Ponzoni L; Luo A; Zhu R; He M; Huang Y; Guan KL; Bahar I; Liu Z; Wan Y
Cancer Res; 2020 Jun; 80(12):2550-2563. PubMed ID: 32269044
[TBL] [Abstract][Full Text] [Related]
19. Mucin O-glycosylating enzyme GALNT2 facilitates the malignant character of glioma by activating the EGFR/PI3K/Akt/mTOR axis.
Sun Z; Xue H; Wei Y; Wang C; Yu R; Wang C; Wang S; Xu J; Qian M; Meng Q; Li G
Clin Sci (Lond); 2019 May; 133(10):1167-1184. PubMed ID: 31076460
[TBL] [Abstract][Full Text] [Related]
20. Activated-PAK4 predicts worse prognosis in breast cancer and promotes tumorigenesis through activation of PI3K/AKT signaling.
He LF; Xu HW; Chen M; Xian ZR; Wen XF; Chen MN; Du CW; Huang WH; Wu JD; Zhang GJ
Oncotarget; 2017 Mar; 8(11):17573-17585. PubMed ID: 28407679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
